Indication
Congenital Cytomegalovirus Infection
3 clinical trials
4 products
Clinical trial
Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection With Gestational Age ≤ 14 Weeks - an Open-label, Single-arm, Prospective Trial Investigating Efficacy and Safety of Cytotect CP BiotestStatus: Active (not recruiting), Estimated PCD: 2023-12-31
Product
BT097Clinical trial
A Phase I Pharmacokinetic and Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital CytomegalovirusStatus: Not yet recruiting, Estimated PCD: 2025-01-13
Product
LetermovirClinical trial
A Phase II Open-Label Randomized Study of Anti-Viral Antibiotic Therapy With and Without Familial (Maternal) Cytomegalovirus (CMV) Cytotoxic T Lymphocytes (CTLs) in Neonates With Moderate/Severe Maternal Acquired CMV InfectionStatus: Recruiting, Estimated PCD: 2027-10-31
Product
CMV Cytotoxic T-LymphocytesProduct
Anti-viral Therapy